AQR Capital Management LLC Purchases New Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

AQR Capital Management LLC purchased a new position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 7,151 shares of the medical instruments supplier’s stock, valued at approximately $478,000. AQR Capital Management LLC owned about 0.20% of Utah Medical Products as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Bank of Montreal Can acquired a new position in Utah Medical Products during the second quarter worth $1,039,000. Dimensional Fund Advisors LP increased its stake in shares of Utah Medical Products by 5.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 170,310 shares of the medical instruments supplier’s stock worth $11,378,000 after purchasing an additional 8,700 shares during the last quarter. American Century Companies Inc. lifted its stake in Utah Medical Products by 18.1% in the 2nd quarter. American Century Companies Inc. now owns 11,921 shares of the medical instruments supplier’s stock valued at $796,000 after purchasing an additional 1,830 shares during the last quarter. Rice Hall James & Associates LLC lifted its stake in Utah Medical Products by 3.8% in the 2nd quarter. Rice Hall James & Associates LLC now owns 67,041 shares of the medical instruments supplier’s stock valued at $4,479,000 after purchasing an additional 2,427 shares during the last quarter. Finally, Isthmus Partners LLC grew its holdings in Utah Medical Products by 12.3% during the second quarter. Isthmus Partners LLC now owns 39,967 shares of the medical instruments supplier’s stock worth $2,670,000 after purchasing an additional 4,365 shares during the period. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Up 0.3 %

NASDAQ:UTMD opened at $66.52 on Tuesday. The firm has a market capitalization of $234.68 million, a price-to-earnings ratio of 14.78 and a beta of 0.08. Utah Medical Products, Inc. has a 12-month low of $64.90 and a 12-month high of $87.86. The stock’s 50 day moving average price is $66.80 and its two-hundred day moving average price is $67.80.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. The firm had revenue of $10.40 million during the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 4th. Shareholders of record on Friday, September 20th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, September 20th. This represents a $1.20 annualized dividend and a yield of 1.80%. Utah Medical Products’s dividend payout ratio is currently 26.67%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.